Company Lipidor AB

LIPI

SE0012558617

Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Company contact information

Sector

Annual profits - Rate of surprise

Sector Other Pharmaceuticals

Market Closed - Nasdaq Stockholm Other stock markets 08:44:20 13/05/2024 pm IST			5-day change	1st Jan Change
0.22 ^SEK	-0.45%		-3.51%	-56.35%

22/04	Lipidor AB Postpones the Publication of Annual Report for 2023	CI
21/03	Lipidor AB Announces Approval for Start of Phase III Clinical Trial of Psoriasis Candidate AKP02G2	CI

Lipidor AB is a Sweden-based drug delivery company focusing on topical medication. The Company is focused to develop, patent and commercialize formulation concepts and technologies based on lipids. The Company develops product concepts based on AKVANO technology, which represents a dosage form that creates a lipid layer on the skin surface for effective delivery of drugs and skin care treatment. The Companyâs cooperation partners include Cerbios-Pharma, which specializes in the development and manufacturing of chemical and biological active pharmaceutical ingredients (APIs), and Aurena Laboratories AB, a manufacturer of bag-on-valve aerosol sprays for the pharmaceutical and medical device industry.

Number of employees: 8

SEK in Million	2021	Weight	2022	Weight	Delta
Drugs for the Treatment of Skin Diseases 100.0 %	15	100.0 %	0	100.0 %	-99.71%

SEK in Million	2021	Weight	2022	Weight	Delta
Sweden 100.0 %	15	100.0 %	0	100.0 %	-99.71%

Managers	Title	Age	Since
Ola Holmlund CEO	Chief Executive Officer	55	01/18/01
Jan Holmbäck FOU	Founder	67	01/09/01
Charlotta Ekman DFI	Director of Finance/CFO	43	01/22/01
Anders Hagman PRN	Corporate Officer/Principal	-	01/20/01

Members of the board	Title	Age	Since
Gunilla Lundmark BRD	Director/Board Member	61	01/19/01
Denis Angioletti BRD	Director/Board Member	56	01/20/01
Ola Flink BRD	Director/Board Member	80	01/17/01
Sten Gunnar Otto Skolling BRD	Director/Board Member	62	01/20/01
Karl Fredrik Sjövall CHM	Chairman	44	01/18/01

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	28,976,863	18,910,757 ( 65.26 %)	0	65.26 %

Lipidor AB

Karolinska Institutet Science Park Fogdevreten 2

171 65, Solna

+46 7 25 07 03 69

http://www.lipidor.se

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals

	1st Jan change	Capi.
LIPIDOR AB	-56.35%	591K
ELI LILLY AND COMPANY	+29.98%	684B
NOVO NORDISK A/S	+30.34%	568B
JOHNSON & JOHNSON	-3.52%	361B
MERCK & CO., INC.	+18.59%	329B
ABBVIE INC.	+4.07%	284B
ASTRAZENECA PLC	+16.21%	240B
NOVARTIS AG	+9.66%	208B
ROCHE HOLDING AG	-6.83%	200B
AMGEN INC.	+7.09%	166B

Other Pharmaceuticals